1. Home
  2. XELB vs VTGN Comparison

XELB vs VTGN Comparison

Compare XELB & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

N/A

Current Price

$0.33

Market Cap

8.4M

Sector

Miscellaneous

ML Signal

N/A

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

N/A

Current Price

$0.18

Market Cap

9.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XELB
VTGN
Founded
2011
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
9.5M
IPO Year
2011
2014

Fundamental Metrics

Financial Performance
Metric
XELB
VTGN
Price
$0.33
$0.18
Analyst Decision
Buy
Hold
Analyst Count
2
4
Target Price
★ $4.00
$1.00
AVG Volume (30 Days)
628.8K
★ 718.4K
Earning Date
11-16-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 48.37
N/A
EPS
N/A
★ N/A
Revenue
★ N/A
N/A
Revenue This Year
$30.13
$33.96
Revenue Next Year
$99.55
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.27
$0.17
52 Week High
$2.47
$5.14

Technical Indicators

Market Signals
Indicator
XELB
VTGN
Relative Strength Index (RSI) 36.51 43.57
Support Level $0.29 $0.17
Resistance Level $0.58 $0.32
Average True Range (ATR) 0.09 0.01
MACD 0.02 0.00
Stochastic Oscillator 16.79 64.29

Price Performance

Historical Comparison
XELB
VTGN

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

Share on Social Networks: